Latest Articles
NHS women’s health strategy targets ‘medical gaslighting’ - Pharmacy Business
NHS women’s health strategy targets ‘medical gaslighting’ Pharmacy Business
Published: April 17, 2026, 8:48 a.m.
ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones - TradingView — Track All Markets
ABSI: ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones TradingView — Track All Markets
Published: April 16, 2026, 8:21 p.m.
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target - TipRanks
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target TipRanks
Published: April 15, 2026, 9:42 p.m.
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy - TipRanks
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy TipRanks
Published: April 15, 2026, 1:38 p.m.
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses Frontiers
Published: April 15, 2026, 10:36 a.m.
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer - Targeted Oncology
Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer Targeted Oncology
Published: April 14, 2026, 5:46 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
PORTAL MADNESS: Scott Drew STEALS Elite Kentucky Target, He Wants to DESTROY Mark Pope? - newscentermaine.com
PORTAL MADNESS: Scott Drew STEALS Elite Kentucky Target, He Wants to DESTROY Mark Pope? newscentermaine.com
Published: April 13, 2026, 1:54 a.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - KELO-AM
GSK sees blockbuster potential in targeted cancer therapy after promising early data KELO-AM
Published: April 12, 2026, 8:44 p.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - KFGO
GSK sees blockbuster potential in targeted cancer therapy after promising early data KFGO
Published: April 12, 2026, 8:44 p.m.
Link copied to clipboard!